130 related articles for article (PubMed ID: 2090768)
1. Influence of new quinolones on normal immune capabilities.
Tawfik AF; Shoeb HA; Bishop SJ; al-Shammary FJ; Shibl AM
J Chemother; 1990 Oct; 2(5):300-5. PubMed ID: 2090768
[TBL] [Abstract][Full Text] [Related]
2. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
Syrjälä H; Schildt R; Räisäinen S
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):68-70. PubMed ID: 1864276
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
5. [The effects of ciprofloxacin and ofloxacin on the cellular and humoral immune response in mice].
Usluer G; Ulak G; Erol K; Gürer F; Cingi MI; Ozdemir M; Alpan RS
Mikrobiyol Bul; 1991 Oct; 25(4):330-9. PubMed ID: 1795657
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinolones on granulocyte function in vitro.
Boogaerts MA; Malbrain S; Scheers W; Verwilghen RL
Infection; 1986; 14 Suppl 4():S258-62. PubMed ID: 3469158
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone derivatives: effects on neutrophil functional tests.
Bersani C; Santagada T; Bertoletti R; Fietta A; Gialdroni Grassi G
Chemioterapia; 1987 Jun; 6(2 Suppl):222-3. PubMed ID: 3334562
[No Abstract] [Full Text] [Related]
9. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
10. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S72-5. PubMed ID: 3481439
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
[TBL] [Abstract][Full Text] [Related]
12. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
Yassien M; Khardori N
Diagn Microbiol Infect Dis; 2001 Jul; 40(3):79-89. PubMed ID: 11502373
[TBL] [Abstract][Full Text] [Related]
13. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
[TBL] [Abstract][Full Text] [Related]
14. The influence of quinolones on the faecal flora.
Midtvedt T
Scand J Infect Dis Suppl; 1990; 68():14-8. PubMed ID: 2218416
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Scazzocchio F; Selan L; Oliva B; Schippa S; Cellini L; Renzini G
Chemioterapia; 1988 Oct; 7(5):295-7. PubMed ID: 3066516
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
[TBL] [Abstract][Full Text] [Related]
17. The comparative pharmacokinetics of five quinolones.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
[TBL] [Abstract][Full Text] [Related]
19. Modulation of biofilms of Pseudomonas aeruginosa by quinolones.
Yassien M; Khardori N; Ahmedy A; Toama M
Antimicrob Agents Chemother; 1995 Oct; 39(10):2262-8. PubMed ID: 8619580
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
